Drugmakers embracing AI’s utility to uncover hidden opportunities in discovery
In a bad year, only a small percentage of people vaccinated against the flu are actually protected. But now researchers are using AI and computer models to change that.
Reporter Matt Reynolds highlights BERG’s commitment to using individual patient biologies to develop vaccines that are more specific and effective, citing BERG’s ongoing partnership with Sanofi this flu season.
To read the full article, click here.